| Project description
The company which submitted the application, Corline AB, is a high-tech
company at the very fore-front of research, development and manufacturing of
biocompatible surfaces for medical devices in contact with blood.
The goal of the project was to explore the mechanisms for antithrombin
interaction with immobilised heparin as related to the molecular structure
of the immobilised heparin and the implications for cellular reactions and
performance in whole blood tests. The collaborating research partner was
Professor Rolf Larsson at UU, also a Project Leader for the project
“A systematic approach to improve blood compatibility of biomaterials for
cardiovascular applications”.
”The activities within this research project are excellent illustrations
of a mutually beneficial collaboration between industry and academia”,
says Professor Larsson. ”Industry, in this case Corline, provides interesting
and relevant study objects and questions, and academia can use their
sophisticated instruments and knowledge as part of an ongoing education of
young scientists to provide useful answers published in peer-reviewed
scientific reports.”
|